Elizabeth Zhang-Velten

Clinical Assistant Professor of Radiation Oncology (Practitioner)

Image of Elizabeth Zhang-Velten
Is this your profile? Click to edit

Awards

  • University of Texas Southwestern Radiation Oncology Residency: Resident Research Award, 2022
  • American Society of Clinical Oncology: ASCO Young Investigator Award, 2021
  • American Society for Radiation Oncology: ASTRO Research Award, 2021
  • Massachusetts Institute of Technology: Burchard Scholar, 2006

Publications

  • Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment OutcomesTransplant Cell Ther. 2022 02; 28(2):113. e1-113. e8. . View in PubMed
  • A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution Pract Radiat Oncol. 2022 May-Jun; 12(3):e177-e182. . View in PubMed
  • The Evolving Role of Hypofractionated Radiotherapy in Older Adults with Gastrointestinal Cancers Semin Radiat Oncol. 2022 04; 32(2):159-167. . View in PubMed
  • Hypofractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer-Does Size Matter? -Reply. JAMA Oncol. 2022 03 01; 8(3):481.. View in PubMed
  • Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial JAMA Oncol. 2021 Oct 01; 7(10):1497-1505. . View in PubMed
  • Patterns of Dose Escalation Among Patients With Esophageal Cancer Undergoing Definitive Radiation Therapy: 2006-2016 Adv Radiat Oncol. 2021 Mar-Apr; 6(2):100580. . View in PubMed
  • Thirteen-Year Survival in a Patient With Diffuse Bilateral Lepidic-Predominant Adenocarcinoma: A Case Report of Lung Transplantation and Local Salvage JTO Clin Res Rep. 2020 Nov; 1(4):100094. . View in PubMed
  • Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy Oncoimmunology. 2018; 7(7):e1440168. . View in PubMed

Similar People